Comparative quantitative proteomics of tumoral and peritumoral tissues for distinguishing human glioblastoma from low-grade astrocytoma

This publication has 41 references indexed in Scilit:

• Neuron-like lineage differentiation induced by exogenous Neurexin-1 as a potential therapeutic strategy for glioma
  Cancer Letters, 2024
• Splicing dysregulation in glioblastoma alters the function of cell migration‐related genes
  Glia, 2024
• A Review on Caspases: Key Regulators of Biological Activities and Apoptosis
  Molecular Neurobiology, 2023
• NEDD4 degrades TUSC2 to promote glioblastoma progression
  Cancer Letters, 2022
• Necrotic reshaping of the glioma microenvironment drives disease progression
  Acta Neuropathologica, 2022
• G-protein-coupled receptors as therapeutic targets for glioblastoma
  Drug Discovery Today, 2021
• Design, synthesis and biological evaluation of novel histone deacetylase1/2 (HDAC1/2) and cyclin-dependent Kinase2 (CDK2) dual inhibitors against malignant cancer
  European Journal of Medicinal Chemistry, 2020
• Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting
  Cancer Letters, 2019
• Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
  Cell, 2016
• Tenascin-R: Role in the central nervous system
  The International Journal of Biochemistry & Cell Biology, 2012